Abstract

BackgroundWhether TNF-related apoptosis-inducing ligand (TRAIL) impacts cardiovascular risk in rheumatoid arthritis (RA) is currently unknown.ObjectivesWe examined the association of TRAIL concentrations with cardiovascular disease (CVD) in RA and, since osteoprotegerin...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call